Adherence to routinely prescribed medications among paediatric sickle cell disease patients in Kumasi, Ghana
- PMID: 40927067
- PMCID: PMC12416217
- DOI: 10.4314/gmj.v58i2.2
Adherence to routinely prescribed medications among paediatric sickle cell disease patients in Kumasi, Ghana
Abstract
Objective: To measure the adherence to routinely prescribed medications among Sickle Cell Disease (SCD) patients in Kumasi, Ghana.
Design: A cohort study involving paediatric SCD patients presenting to the outpatient clinic at the Komfo Anokye Teaching Hospital (KATH).
Setting: The Pediatric SCD Outpatient Clinic of KATH.
Participants: Two hundred SCD patients visiting the outpatient clinic.
Intervention: None.
Main outcome measure: Cost and adherence to Penicillin V, Folic Acid, Hydroxyurea and Vitamins prescribed to SCD patients on routine outpatient visits.
Results: Of the 200 participants, the highest and lowest phenotypes were Hb-SS (162, 80.1%) and Sβ-thal (3, 1.5%), respectively. The adherence rate to routine medications was 13.5% (95%CI: ut9.1% to 19.0%). Patient factors that affect adherence included forgetfulness 98(49%), cost 54(27%), and side effects 28(14%) of medication, and improvement in health 7(3.5%). Hydroxyurea was the costliest to the patients with a median (IQR) cost of GHc 75 (0, 450) or USD12 (0, 73), and the least was folic acid with a median of GHc 6 (0, 42) or USD 1 (0, 7). 44.5% of all medications prescribed were not obtained in full. 83% of those who did not purchase all the medicines attributed this to cost, with 13% indicating they had some at home.
Conclusion: There is low adherence to routine medications used by SCD patients in Kumasi, and this could be because of their relatively high cost. Further studies should be made to assess the non-adherent effects of SCD medications on patients' health.
Funding: This work was funded by the Sickle Pan-African Research Consortium (SPARCO), Kumasi-Ghana site.
Keywords: Adherence; Ghana; Sickle Cell Disease.
Copyright © The Author(s).
Conflict of interest statement
Conflict of interest: None declared
References
-
- Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK. Medication compliance and persistence: terminology and definitions. Value Health. 2008 Jan-Feb;11(1):44–44. doi: 10.1111/j.1524-4733.2007.00213.x. PMID: 18237359. - PubMed
-
- Lynch SS. Adherence to a drug regimen-Clinical Pharmacology. MSD Manual. Com. 2022.
-
- Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994 Jun 9;330(23):1639–1644. doi:10.1056/NEJM199406093302303. PMID: 7993409. - PubMed
-
- Data and Statistics on Sickle Cell Disease (CDC), author 2023. www.Cdc.gov. /ncbddd/sickle cell disease.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical